Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
US7645752B2 · kind B2 · utility
55Cited by
34References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2007 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Feb 9, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula I:which are modulators of the 5-hydroxtryptamine-6 and 5-hydroxytryptamine-2A receptors and which are inhibitors of norepinephrine reuptake. The compounds of the invention, and pharmaceutical composition thereof, are useful in the treatment of disorders related to or associated with the 5-hydroxytryptamine-6 and 5-hydroxtryptamine-2A receptors or with norepinephrine reuptake inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.